Delgocitinib for Chronic Hand Eczema [ID6688]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Amlitelimab for treating moderate to severe atopic dermatitis in people 12 years and over [GID-TA12005]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC